Selection of patients with hepatocellular carcinoma before liver transplantation:need to combine alpha-fetoprotein with morphology?

被引：2
|
作者：
Christian Toso [1 ]
Gilles Mentha [1 ]
Pietro Majno [1 ]
机构：
[1] Abdominal and Transplant Surgery,University Hospitals of Geneva
来源：
Hepatobiliary & Pancreatic Diseases International | 2010年 / 9卷 / 05期
关键词：
HCC; AFP; Selection of patients with hepatocellular carcinoma before liver transplantation;
D O I：
暂无
中图分类号：
R735.7 [肝肿瘤];
学科分类号：
100214 ;
摘要：
Liver transplantation is the best treatment for selected patients with unresectable hepatocellular carcinoma (HCC). While candidate selection has been historically based on the restrictive Milan
引用
收藏
页码：460 / 461
页数：2
相关论文
共 50 条
  • [41] The Diagnostic and Prognostic Value of Des-Gamma-Carboxyprothrombin and Alpha-Fetoprotein in Hepatocellular Carcinoma Patients Accepting Liver Transplantation
    Guo, Haijun
    Xu, Xiao
    Liu, Zhikun
    Wei, Xuyong
    Wei, Qiang
    Ke, Qinghong
    Zheng, ShuSen
    TRANSPLANTATION, 2015, 99 : 223 - 223
  • [42] The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma
    Tomokuni, Akira
    Kobayashi, Shogo
    Wada, Hiroshi
    Asukai, Kei
    Yamada, Daisaku
    Akita, Hirofumi
    Takahashi, Hidenori
    Omori, Takeshi
    Yasui, Masayoshi
    Miyata, Hiroshi
    Ohue, Masayuki
    Yano, Masahiko
    Sakon, Masato
    CANCER SCIENCE, 2018, 109 : 939 - 939
  • [43] Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
    Wong Hoi She
    Albert Chi Yan Chan
    Tan To Cheung
    Chung Mau Lo
    Kenneth Siu Ho Chok
    World Journal of Hepatology, 2018, (02) : 308 - 318
  • [44] Survival outcomes of liver transplantation for hepatocellular carcinoma in patients with normal, high and very high preoperative alpha-fetoprotein levels
    She, Wong Hoi
    Chan, Albert Chi Yan
    Cheung, Tan To
    Lo, Chung Mau
    Chok, Kenneth Siu Ho
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (02) : 308 - 318
  • [45] Racial disparities in alpha-fetoprotein testing and alpha-fetoprotein status associated with the diagnosis and outcome of hepatocellular carcinoma patients
    Wu, Guoyi
    Wu, Jing
    Pan, Xiaoben
    Liu, Bo
    Yao, Zhicheng
    Guo, Yuan
    Shi, Xiaolei
    Ding, Yitao
    CANCER MEDICINE, 2019, 8 (15): : 6614 - 6623
  • [46] Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma
    Bhat, M.
    Hassanain, M.
    Simoneau, E.
    Tzimas, G. N.
    Chaudhury, P.
    Deschenes, M.
    Valenti, D.
    Ghali, P.
    Wong, P.
    Cabrera, T.
    Barkun, J.
    Tchervenkov, J. I.
    Metrakos, P.
    CURRENT ONCOLOGY, 2013, 20 (05) : 265 - 272
  • [47] Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma
    Soresi, M
    Magliarisi, C
    Campagna, P
    Leto, G
    Bonfissuto, G
    Riili, A
    Carroccio, A
    Sesti, R
    Tripi, S
    Montalto, G
    ANTICANCER RESEARCH, 2003, 23 (2C) : 1747 - 1753
  • [48] EXCESSIVE ALPHA-FETOPROTEIN CONCENTRATIONS IN HEPATOCELLULAR CARCINOMA
    AMERY, AH
    ALSTON, WC
    KOHN, J
    WHITE, WF
    BRITISH MEDICAL JOURNAL, 1977, 2 (6087): : 611 - 612
  • [49] Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
    Galle, Peter R.
    Foerster, Friedrich
    Kudo, Masatoshi
    Chan, Stephen L.
    Llovet, Josep M.
    Qin, Shukui
    Schelman, William R.
    Chintharlapalli, Sudhakar
    Abada, Paolo B.
    Sherman, Morris
    Zhu, Andrew X.
    LIVER INTERNATIONAL, 2019, 39 (12) : 2214 - 2229
  • [50] Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation
    Marubashi, S.
    Dono, K.
    Sugita, Y.
    Asaoka, T.
    Hama, N.
    Gotoh, K.
    Miyamoto, A.
    Takeda, Y.
    Nagano, H.
    Umeshita, K.
    Monden, M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3640 - 3642
12345